CELLCURA ASA - MINUTES FROM EXTRAORDINARY GENERAL MEETING

On 21 November 2014, an extraordinary general meeting was held in CellCura ASA.

On the agenda were the proposals to raise a convertible loan of NOK 12,055,190 and that the Board of Directors was authorised to enter into additional convertible loan agreements and to issue new shares through share capital increases. All decisions were approved in accordance with the propositions from the Board of Directors.

The minutes from the extraordinary general meeting is attached hereto.

Oslo, 21 November 2014
CellCura ASA
Tore Viana-Rønningen
Chief Executive Officer
Phone: + 47 911 08 693

CellCura ASA is dedicated to the development and sales of cell technologies for use in assisted reproductive technology (ART) and stem cell research worldwide, representing improved safety and efficiency compared to traditional technology. CellCura is listed on the Oslo Axess market at the Oslo Stock Exchange (ticker: CELL)

www.cellcura.com

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

distributed by